Showing results (971-980 of 1,625) with videos related to
Sort By:
Pageof 163
Kidney International. Supplement|July 17, 2003
Nephrology in China: a great mission and momentous challengeShanyan LinKidney International. Supplement|July 17, 2003
Burden of end-stage renal disease among indigenous peoples in Australia and New ZealandStephen P McDonald, Graeme R RussKidney International. Supplement|October 9, 2003
Erythropoietin should be part of congestive heart failure managementDonald S Silverberg, Dov Wexler, Miriam Blum, et al.Kidney International. Supplement|February 12, 2004
Clinical indices of in vivo biocompatibility: the role of ex vivo cell function studies and effluent markers in peritoneal dialysis patientsRuth Mackenzie, Clifford J Holmes, Suzanne Jones, et al.Kidney International. Supplement|February 12, 2004
Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysisMax Dratwa, Martin Wilkie, Jean-Philippe Ryckelynck, et al.Kidney International. Supplement|April 16, 2003
New insights in uremic toxinsRaymond Vanholder, Griet Glorieux, Rita De Smet, et al.Kidney International. Supplement|April 16, 2003
5-Lipoxygenase-mediated mitochondrial damage and apoptosis of mononuclear cells in ESRD patientsMauro Maccarrone, Massimo Taccone-Gallucci, Alessandro Finazzi-AgròKidney International. Supplement|April 16, 2003
Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patientsMarta Kalousová, Tomás Zima, Vladimír Tesar, et al.Kidney International. Supplement|April 16, 2003
Uremia-associated immune defect: the IL-10-CRP axisMatthias Girndt, Christof Ulrich, Harald Kaul, et al.Kidney International. Supplement|April 16, 2003
Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patientsGérard M London, Sylvain J Marchais, Alain P Guerin, et al.Pageof 163